Clinicopathological characteristics and prognosis of diffuse large B-cell lymphoma in relation to CA-125 and CA 19-9 expression
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL
Y Suzuki, T Yoshida, G Wang, T Togano… - Annals of …, 2012 - Springer
Diffuse large B-cell lymphomas (DLBCL) express CD20. CD20 expression is described as
negative, weak, or normal as determined by flow cytometry (FCM) and is an important target …
negative, weak, or normal as determined by flow cytometry (FCM) and is an important target …
[HTML][HTML] Prognostic implication of semi-quantitative immunohistochemical assessment of CD20 expression in diffuse large B-cell lymphoma
CH Choi, YH Park, JH Lim, SJ Choi… - … of Pathology and …, 2016 - synapse.koreamed.org
Background: Immunohistochemical demonstration of CD20 in diffuse large B-cell lymphoma
(DLBCL) is prerequisite not only for the diagnosis but also for assigning patients to rituximab …
(DLBCL) is prerequisite not only for the diagnosis but also for assigning patients to rituximab …
Serum carbohydrate antigen 125 concentration as a superior predictor for serosal effusion at diagnosis and a prognostic factor in diffuse large B-cell lymphoma
JZ Wu, T Tian, Y Huang, JH Liang, Y Miao… - Cancer …, 2016 - content.iospress.com
BACKGROUND: Carbohydrate antigen 125 (CA-125) is one of the most common used
tumor biomarkers in clinical practice. Previous studies showed an association of increased …
tumor biomarkers in clinical practice. Previous studies showed an association of increased …
[HTML][HTML] CD30 immunohistochemical expression in diffuse large B-cell lymphoma is associated with decreased overall survival and the non-germinal center molecular …
Background Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease entity with
multiple potential prognostic biomarkers. Cell of origin (COO) molecular subtype …
multiple potential prognostic biomarkers. Cell of origin (COO) molecular subtype …
The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma
X Hao, X Wei, F Huang, Y Wei, H Zeng, L Xu, Q Zhou… - PloS one, 2015 - journals.plos.org
The prognostic value of CD30 expression indiffuse large B-cell lymphoma (DLBCL) remains
controversial. Herein, we performed this retrospective study to investigate the clinical and …
controversial. Herein, we performed this retrospective study to investigate the clinical and …
[HTML][HTML] CD30 Expression in Diffuse Large B-Cell Lymphoma and Its Relation to Important Clinical and Biological Disease Features
G Campuzano-Zuluaga, M Cioffi-Lavina, IS Lossos… - Blood, 2012 - Elsevier
Abstract 1592 Background: CD30 is a well-known diagnostic marker in both anaplastic large
cell lymphoma (ALCL) and classical Hodgkin's lymphoma (CHL). Recently the chimeric drug …
cell lymphoma (ALCL) and classical Hodgkin's lymphoma (CHL). Recently the chimeric drug …
Prognostic value of serum CA125 levels in diffuse large B‐cell lymphoma: potential role of a new sex‐and age‐adjusted reference value
A Gutiérrez, J MARTÍNEZ‐SERRA… - … journal of laboratory …, 2010 - Wiley Online Library
CA125, a tumor marker normally used to follow the clinical course of ovarian cancer, also
may have a role in lymphoma. All available series were analyzed using the standard …
may have a role in lymphoma. All available series were analyzed using the standard …
Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma
O Bairey, D Blickstein, P Stark, M Prokocimer… - Leukemia & …, 2003 - Taylor & Francis
Cancer antigen 125 (CA 125) is a glycoprotein expressed in normal tissues originally
derived from coelomic epithelia such as peritoneum, pleura, pericardium, fallopian tubes …
derived from coelomic epithelia such as peritoneum, pleura, pericardium, fallopian tubes …
Prognostic significance of CD30 expression in diffuse large B‐cell lymphoma: A systematic review with meta‐analysis
CI Rodrigues‐Fernandes, LG Abreu… - Journal of Oral …, 2021 - Wiley Online Library
Background CD30 is variably expressed in diffuse large B‐cell lymphoma (DLBCL), but its
prognostic potential for the affected patients remains debatable and unclear. Therefore, we …
prognostic potential for the affected patients remains debatable and unclear. Therefore, we …